In this episode of "The Eyes on Washington Podcast," Public Policy & Regulation attorneys Michael Werner, Sara Klock, Joshua Odintz and Ed Perlmutter discuss the proposed rule by the U.S. Drug Enforcement Administration (DEA) to move marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act. They explore how the reclassification could impact federal and state regulation, U.S. tax policy, banking rules and product approvals. The discussion also highlights the need for stakeholders to carefully engage See more +

In this episode of "The Eyes on Washington Podcast," Public Policy & Regulation attorneys Michael Werner, Sara Klock, Joshua Odintz and Ed Perlmutter discuss the proposed rule by the U.S. Drug Enforcement Administration (DEA) to move marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act. They explore how the reclassification could impact federal and state regulation, U.S. tax policy, banking rules and product approvals. The discussion also highlights the need for stakeholders to carefully engage with these evolving regulatory changes. See less -